UNIVERSITY OF WATERLOO
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1956-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://uwaterloo.ca/
Clinical Trials
83
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (68 trials with phase data)• Click on a phase to view related trials
Quantifying Ocular Surface Aberrations After Tear Film Interventions
- Conditions
- Tear Film Characteristics
- Interventions
- Drug: Systane Complete Preservative-FreeDevice: Senofilcon ADevice: Somofilcon A
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- University of Waterloo
- Target Recruit Count
- 12
- Registration Number
- NCT06966349
Validation and Testing of a Novel Continuous Glucose and Continuous Ketone Monitoring Device in Healthy Volunteers
- Conditions
- Diabetes Ketoacidosis
- First Posted Date
- 2025-03-14
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- University of Waterloo
- Target Recruit Count
- 16
- Registration Number
- NCT06877975
- Locations
- 🇨🇦
University of Waterloo, Waterloo, Ontario, Canada
Virtual Intervention for Vertebral frActure: a Pilot, Feasibility Study for a Multicentre Randomized Controlled Trial
- Conditions
- OsteoporosisFractures, Spinal
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- University of Waterloo
- Target Recruit Count
- 32
- Registration Number
- NCT06650410
- Locations
- 🇨🇦
Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada
🇨🇦Arthritis Research Canada, Vancouver, British Columbia, Canada
🇨🇦Geras Centre for Aging Research, Hamilton, Ontario, Canada
Visual Performance of Dailies Total1 Multifocal and Acuvue Oasys Max 1-Day Multifocal in Presbyopic Lens Wearers
- Conditions
- Presbyopia
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- University of Waterloo
- Target Recruit Count
- 28
- Registration Number
- NCT06369987
- Locations
- 🇨🇦
Centre for Ocular Research & Education (CORE), Waterloo, Ontario, Canada
Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use
- Conditions
- Myopia
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University of Waterloo
- Target Recruit Count
- 41
- Registration Number
- NCT06308666
- Locations
- 🇨🇦
Centre for Ocular Research & Education, Waterloo, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
News
Revive Therapeutics Advances Bucillamine Development for Long COVID Treatment Through Manufacturing Partnership
Revive Therapeutics has partnered with Attwill Medical Solutions to develop a novel lyophilized formulation of Bucillamine, with enhanced solubility showing more than double improvement over standard formulations.